Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Frank M. Sands

10% Owner at Inhibikase Therapeutics, Inc. (IKT)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+16.1%
vs. S&P 500+13.8%
Beat the market100%
Paper profit on buys+$1.1M
Total bought / sold$3.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Nov 24SEC IKTInhibikase Therapeutics, Inc. Buy 2,068,96513,018,965 held (+19%) $1.45 $3.0M +35.9%
  • Buy

    10% Owner Frank M. Sands bought $3.0M of IKT at $1.45 — first open-market purchase in our records.